BridgeBio Pharma Inc (BBIO) financials · rev $502.1M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
BridgeBio Pharma Inc (BBIO) rev $502.1M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $502.1M | $221.9M |
| Cost of Revenue | $21.0M | $3.88M |
| Gross Profit | $481.1M | $218.0M |
| Operating Income | -$523.4M | -$593.0M |
| Net Income | -$732.9M | -$543.3M |
| EPS (Diluted) | -$3.78 | -$2.88 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $936.0M | $919.3M |
| Current Assets | $797.7M | $720.7M |
| Cash & Equivalents | $570.1M | $681.1M |
| Inventory | $26.8M | $0 |
| PP&E | $5.37M | $7.01M |
| Total Liabilities | $3.01B | $2.38B |
| Current Liabilities | $288.0M | $154.4M |
| Long-term Debt | $2.01B | $437.3M |
| Total Debt | $2.01B† | $437.3M† |
| Shareholders' Equity | -$2.09B | -$1.47B |
| Retained Earnings | -$3.82B | -$3.10B |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$445.9M | -$520.7M |
| CapEx | $1.10M | $933.0K |
| Investing Cash Flow | -$24.5M | $60.8M |
| Financing Cash Flow | $359.3M | $748.5M |
| Net Change in Cash | -$111.1M | $288.5M |
| Free Cash Flow | -$447.0M | -$521.7M |
FAQ
What is BBIO P/E and revenue?
BridgeBio Pharma Inc (BBIO) rev $502.1M.
What is BBIO revenue?
BridgeBio Pharma Inc last cached revenue is $502.1M (FY2025).
Is BBIO profitable?
BridgeBio Pharma Inc last cached net income is -$732.9M (FY2025).
What are BBIO total assets?
BridgeBio Pharma Inc last cached total assets are $936.0M (FY2025).
What is BBIO free cash flow?
BridgeBio Pharma Inc last cached free cash flow is -$447.0M (FY2025).
Not investment advice. Cached statements, not a live tape.